| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |